NATUS MEDICAL INC (NTUS) Forecast, Price Target & Analyst Ratings
NASDAQ:NTUS • US6390501038
32.96 USD
+0.03 (+0.09%)
At close: Jul 20, 2022
32.96 USD
0 (0%)
After Hours: 7/20/2022, 8:05:33 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NATUS MEDICAL INC (NTUS).
Forecast Snapshot
Consensus Price Target
$0.00
-100.00% Downside
Next Earnings Forecast
Release DateAug 4, 2022
PeriodQ2 / 2022
EPS Estimate$0.33
Revenue Estimate122.808M
ChartMill Buy Consensus
43.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $32.96 to mean target of $0.00, Based on 6 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
NTUS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NTUS.
In the previous month the buy percentage consensus was at a similar level.
NTUS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateAug 4, 2022
PeriodQ2 / 2022
EPS Estimate$0.33
Revenue Estimate122.808M
Revenue Q2Q5.89%
EPS Q2Q12.55%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
NTUS is expected to report earnings on 8/4/2022. The consensus EPS estimate for the next earnings is 0.33 USD and the consensus revenue estimate is 122.81M USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 495.2M -6.72% | 415.7M -16.05% | 473.44M 13.89% | 504.9M 6.64% | 527.544M 4.48% | 541.975M 2.74% | 567.937M 4.79% | |
| EBITDA YoY % growth | 59.72M 28.54% | 18.12M -69.66% | 57.47M 217.16% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 29M 130.16% | -10M -134.48% | 29.38M 393.80% | 66.912M 127.75% | 73.338M 9.60% | 179.75M 145.10% | 449.375M 150.00% | |
| Operating Margin | 5.86% | -2.41% | 6.21% | 13.25% | 13.90% | 33.17% | 79.12% | |
| EPS YoY % growth | 1.25 -11.97% | 0.39 -68.80% | 1.20 207.69% | 1.47 22.40% | 1.60 9.03% | 1.84 14.83% | 2.15 17.12% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.33 12.55% | 0.38 34.79% | 0.50 6.34% | 0.35 57.64% | 0.36 9.37% | 0.40 5.41% | 0.50 |
| Revenue Q2Q % growth | 122.808M 5.89% | 126.174M 10.80% | 137.904M 7.18% | 124.134M 3.63% | 128.724M 4.82% | 130.458M 3.40% | 144.126M 4.51% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 14.892M 142.94% | 17.136M 123.13% | 22.44M 63.44% | 15.81M 153.77% | 16.32M 9.59% | 18.156M 5.95% | 23.052M 2.73% |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
15.29%
EPS Next 5 Year
15.74%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.10%
Revenue Next 5 Year
4.27%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
NATUS MEDICAL INC / NTUS Forecast FAQ
What is the next earnings date for NTUS stock?
NATUS MEDICAL INC (NTUS) will report earnings on 2022-08-04, after the market close.
What are the consensus estimates for NATUS MEDICAL INC (NTUS) next earnings?
The consensus EPS estimate for the next earnings of NATUS MEDICAL INC (NTUS) is 0.33 USD and the consensus revenue estimate is 122.81M USD.
Can you provide the analyst count for NATUS MEDICAL INC stock?
The number of analysts covering NATUS MEDICAL INC (NTUS) is 6.